You have 9 free searches left this month | for more free features.

Meningeal Neoplasms

Showing 1 - 25 of 761

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Meningeal Tumors, Leptomeningeal Disease Trial in Tübingen (No intervention)

Not yet recruiting
  • Meningeal Neoplasms
  • Leptomeningeal Disease
  • No intervention
  • Tübingen, Germany
    University Hospital Tübingen, Neurooncology
Nov 16, 2023

Clinical, Radiological, Histologic and Molecular Features

Recruiting
  • Meningeal Melanocytoma
  • +3 more
    • Nancy, France
      Nancy University Hospital Center
    Jul 31, 2023

    Patients With Leptomeningeal Metastases ((LM) Using CNSide

    Recruiting
    • Leptomeningeal Metastasis
    • +4 more
    • CNSide
    • Los Angeles, California
      Valkyrie Clinical Trials
    Sep 7, 2022

    CNS/Leptomeningeal Tumors Trial in New York (131I-omburtamab)

    Available
    • Central Nervous System/Leptomeningeal Neoplasms
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jul 15, 2022

    Leptomeningeal Disease, Triple Negative Breast Cancer, HER2-positive Breast Cancer Trial in Tampa (Dendritic Cell Vaccine)

    Recruiting
    • Leptomeningeal Disease
    • +2 more
    • Dendritic Cell Vaccine
    • Tampa, Florida
      Moffitt Cancer Center
    Apr 11, 2023

    Leptomeningeal Metastases, Leptomeningeal Disease Trial in Tampa (Avelumab, Whole Brain Radiotherapy)

    Active, not recruiting
    • Leptomeningeal Metastases
    • Leptomeningeal Disease
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Aug 19, 2022

    HER2-positive Breast Cancer, Leptomeningeal Metastasis, Leptomeningeal Disease Trial in Tampa, Evanston (Radiation Therapy,

    Recruiting
    • HER2-positive Breast Cancer
    • +2 more
    • Radiation Therapy
    • +2 more
    • Tampa, Florida
    • +1 more
    Dec 30, 2022

    Leptomeningeal Disease Trial in Germany (Nivolumab [Opdivo])

    Recruiting
    • Leptomeningeal Disease
    • Nivolumab [Opdivo]
    • Freiburg, Germany
    • +6 more
    Nov 2, 2022

    Patient Perceptions Around Quality of Care Through Telemedicine

    Recruiting
    • Central Nervous System Neoplasm
    • +3 more
    • Electronic Health Record Review
    • Survey Administration
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 19, 2021

    Glioma, Brain Metastases Trial in Shanghai (Autologous progenitor expansion -T, pemetrexed)

    Recruiting
    • Glioma
    • Brain Metastases
    • Shanghai, Shanghai, China
      Fudan University Pudong Medical Center
    Jul 12, 2022

    Breast Cancer Metastatic, Leptomeningeal Metastasis Trial (Tucatinib Oral Tablet, Capecitabine tablets, Trastuzumab Injection)

    Not yet recruiting
    • Breast Cancer Metastatic
    • Leptomeningeal Metastasis
    • Tucatinib Oral Tablet
    • +2 more
    • (no location specified)
    Mar 23, 2023

    Leptomeningeal Tumor, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Tumor in the Brain Trial in United States

    Recruiting
    • Leptomeningeal Neoplasm
    • +6 more
    • Duarte, California
    • +6 more
    Dec 29, 2022

    Acral Lentiginous Melanoma, CNS Melanoma, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial in Houston (Nivolumab)

    Active, not recruiting
    • Acral Lentiginous Melanoma
    • +9 more
    • Biospecimen Collection
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 31, 2023

    Breast Cancer Female, Leptomeningeal Metastases Trial in Charlottesville (HER2 BATs)

    Terminated
    • Breast Cancer Female
    • Leptomeningeal Metastases
    • HER2 BATs
    • Charlottesville, Virginia
      University of Virginia
    Dec 15, 2022

    Patients With Leptomeningeal Disease Trial in Baltimore (Pembrolizumab)

    Terminated
    • Patients With Leptomeningeal Disease
    • Baltimore, Maryland
      Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
    Jan 6, 2021

    Dalpiciclib Combined With Third-generation EGFR-TKI in EGFR

    Not yet recruiting
    • Non-small Cell Lung Cancer Confirmed by Histopathology or Cytology
    • +6 more
      • (no location specified)
      Aug 9, 2022

      NSCLC, EGFR Activating Mutation, Brain Metastases Trial in Beijing (TY-9591 Tablets)

      Recruiting
      • NSCLC
      • +3 more
      • TY-9591 Tablets
      • Beijing, Beijing, China
        National Cancer Center/Cancer Hospitial,Chinese Academy of Medic
      May 14, 2022

      NSCLC, Brain Metastases, Leptomeningeal Metastasis Trial in Zhengzhou (almonertinib, LM-first line treatment, LM-second line

      Recruiting
      • NSCLC
      • +2 more
      • Zhengzhou, Henan, China
        Henan Cancer Hospital
      Aug 25, 2021

      Leptomeningeal Metastasis Trial in Changchun (Pemetrexed, Radiotherapy)

      Recruiting
      • Leptomeningeal Metastasis
      • Changchun, Jilin, China
        The First Hospital of Jilin University
      Jun 8, 2022

      Brain Metastases, Leptomeningeal Metastasis Trial in United States (GDC-0084, whole brain radiation therapy radiation)

      Recruiting
      • Brain Metastases
      • Leptomeningeal Metastasis
      • GDC-0084
      • whole brain radiation therapy radiation
      • Miami, Florida
      • +9 more
      Jan 3, 2023

      NSCLC, Leptomeningeal Metastases, Brain Metastases Trial in United States (Tesevatinib)

      Completed
      • Non-Small Cell Lung Cancer
      • +2 more
      • Beverly Hills, California
      • +6 more
      Mar 7, 2022

      Leptomeningeal Metastasis, Lung Cancer Trial in Hebei (Nimotuzumab)

      Recruiting
      • Leptomeningeal Metastasis
      • Lung Cancer
      • Hebei, Shijiazhuang/hebei, China
      • +1 more
      Apr 18, 2021

      Breast Cancer, Leptomeningeal Metastasis Trial in Lille (Cerebrospinal fluid and blood sample collection at the initial

      Withdrawn
      • Breast Cancer
      • Leptomeningeal Metastasis
      • Cerebrospinal fluid and blood sample collection at the initial diagnostic assessment
      • +2 more
      • Lille, Hauts-de- France, France
      • +1 more
      Oct 5, 2021

      Malignant Meningeal Tumors Trial in United States (Intrathecal Mafosfamide)

      Completed
      • Malignant Meningeal Neoplasms
      • Intrathecal Mafosfamide
      • Los Angeles, California
      • +9 more
      Mar 2, 2020